# Takeda to build €100M+ dengue vaccine plant in Singen, Germany

Takeda Pharmaceuticals announced it will invest more than 100 million euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany. Initial construction will start immediately, and the facility should be ready for production in 2019.

- Type: New facility
- Announced: 2016-11-30
- Where: Singen, Germany, Germany
- Value: $106.0M (100.0M EUR)
- Starts operating: 2019
- Status: announced
- Products: dengue vaccine
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Takeda Pharmaceuticals Company Limited](https://endata.com/companies/20274.md)

## Sources

- [takeda.com](https://www.takeda.com/newsroom/newsreleases/2016/takeda-to-invest-more-than-100-million-euros-in-dengue/), 2016-11-30: "This manufacturing plant investment reinforces Takeda’s strong support for our global vaccine strategy in general, and dengue in particular."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.